See every side of every news story
Published loading...Updated

Reactive Oxidative Species May Play Key Role in Some Chemotherapy Resistance

Summary by Inside Precision Medicine
The cause of chemotherapy resistance is one of the biggest questions in cancer but has proven difficult to address. Now, researchers have found that mutations to VPS35, a key player in the reactive oxygen species (ROS) pathway, can prevent chemotherapy-induced cell death. Specifically, the researchers identified cysteines, a member of the retromer trafficking complex. These results, they suggest, could help pinpoint treatment-resistant tumors.  …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GeneOnline News broke the news in on Sunday, March 30, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.